Skip to main content

Advertisement

Log in

Isostearic acid is an active component of imiquimod formulations used to induce psoriaform disease models

  • Original Article
  • Published:
Inflammopharmacology Aims and scope Submit manuscript

Abstract

Topical imiquimod based creams are indicated as immune stimulants for papillomas and various skin neoplasms. Imiquimod is considered a TLR7 ligand. These creams are also used in research to induce skin inflammation in mice as a model for psoriasis. We observed that this inflammatory response was not strictly imiquimod dependent and we set out to establish which components drive the proinflammatory effects. To this end, we examined the induction response in a BALB/cJRj mouse model, in which 50 mg of cream is applied to 2 cm2 of skin (125 mg/kg imiquimod—5% W/V, and/or 625 mg/kg isostearic acid—25% W/V). Comparing cream formulations containing isostearic acid, imiquimod and the combination, we observed that isostearic acid causes skin inflammation within 2 days, whereas imiquimod requires up to 5 days for initial signs. Isostearic acid activated an inflammasome response, stimulated release of proinflammatory cytokines and upregulated the IL-23/17 axis. Animals treated with isostearic acid had enlarged livers (+ 40% weight), which was not observed with imiquimod alone. Imiquimod was readily metabolized and cleared from plasma and liver, but was maintained at high levels in the skin throughout the body (200 mM at area of application; 200 µM in untreated skin). Imiquimod application was associated with splenomegaly, cytokine induction/release and initial body weight loss over 3 days. Despite high imiquimod skin levels throughout the animal, inflammation was only apparent in the treated areas and was less severe than in isostearic acid groups. As the concentrations in these areas are well above the 10 µM required for TLR7 responses in vitro, there is an implication that skin inflammation following imiquimod is due to effects other than TLR7 agonism (e.g., adenosine receptor agonism). In brain, isostearic caused no major changes in cytokine expression while imiquimod alone sightly stimulated expression of IL-1β and CCL9. However, the combination of both caused brain induction of CCL3, -9, CXCL10, -13, IL-1β and TNFα. The implication of these data is that isostearic acid facilitates the entry of imiquimod or peripherally secreted cytokines into the brain. Our data suggest that psoriaform skin responses in mice are more driven by isostearic acid, than generally reported and that the dose and route used in the model, leads to profound systemic effects, which may complicate the interpretation of drug effects in this model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data availability

Enquiries about data availability should be directed to the authors.

References

Download references

Acknowledgements

We would like to thank colleagues from Synovo GmbH and the University of Tübingen who assisted in this research. Special thanks to the members of the in vivo facility and the team of the analytics/bioanalytics department at both institutions.

Funding

This research received no external funding.

Author information

Authors and Affiliations

Authors

Contributions

All authors have read and agreed to the published version of the manuscript. Conceptualization, SS, TLS and MB; methodology, SS, TLS, MM and MB; validation, SS, TLS and MB; formal analysis, SS, MM and TLS; investigation, JG, SS, SC, MM, MK, TLS, NS, TF and AS; resources, MB and SL; writing—original draft preparation, SS; writing—review and editing, TLS, MB and JHG; visualization, SS; supervision, MB, JHG and SL; project administration, MB; funding acquisition, MB.

Corresponding author

Correspondence to Michael Burnet.

Ethics declarations

Conflict of interest

SS, JG, MM, TF, NC, MK, LR, AS, NS, SC, JHG, TLS are employees of Synovo GmbH. MB is general manager of Synovo GmbH. Synovo provides models of inflammation to the pharmaceutical industry as a service and the investigation of disease model mechanisms is part of this commercial offering.

Institutional review board statement

All study protocols were approved by the local Animal Care and Ethics Committee (Federal government ethics committee, Tübingen, Germany under the license 35/9185.81-7/SYN 07/18).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Straß, S., Geiger, J., Martorelli, M. et al. Isostearic acid is an active component of imiquimod formulations used to induce psoriaform disease models. Inflammopharmacol 31, 799–812 (2023). https://doi.org/10.1007/s10787-023-01175-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10787-023-01175-3

Keywords

Navigation